Advanced Metabolic Reset
The triple agonist, mitochondrial blend and NAD+, the deepest reset in the range.
A mitochondrial blend of MOTS-C and SS-31 in a 40 mg click pen, studied in longevity research.
The high-capacity 40 mg Retatrutide pen, same triple-agonist molecule, double the clicks of active per pen.
High-dose NAD+ in a 1000 mg pen for cellular-energy and longevity research.
Part of our Metabolic & Weight.
related stacksbundle & save
Lean Stack
Dual-agonist weight management with cellular energy underneath.
Tirzepatide 40
NAD+ 1000
bundle & save
Advanced Lean Stack
Triple-agonist fat loss, cellular energy and visceral-fat support, the full lean protocol.
Retatrutide 40
NAD+ 1000
Tesamorelin 20
bundle & save
Metabolic Reset
Mitochondrial support underneath a dual-agonist protocol.
MOTS-C + SS-31 40
Tirzepatide 40
Overview
What this page covers: how the three-pen bundle is composed, what each component is and what it is studied for, and how to confirm pricing and batch documentation before ordering.
Veyvora’s Advanced Metabolic Reset Research Bundle is a three-pen research stack combining MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg, sold as a bundled research purchase at a lower combined price than the three pens acquired separately (Veyvora, 2026) [4]. The bundle is available directly through Veyvora’s site; the bundle price is a live figure, so confirm current pricing at checkout before ordering [4][5].
Confirm bundle availability and pricing at the Veyvora product page before ordering.
| Detail | Specification |
|---|---|
| Product name | Advanced Metabolic Reset Research Bundle |
| Components | MOTS-C + SS-31 40 mg · Retatrutide 40 mg · NAD+ 1000 mg |
| Format | Three multi-dose research pens |
| Price | Confirm at checkout (bundle discount vs. individual pens) |
| Availability | Confirm on the live product page |
| Purchase path | Veyvora.com product page, add bundle to cart |
Veyvora describes the Advanced Metabolic Reset Research Bundle as “the triple agonist, mitochondrial blend and NAD+, the deepest reset in the range” [4][6]. The three pens act through complementary metabolic mechanisms, and each pen carries its own evidence base and CoA [4][6]. Each pen ships with 10 × 31G 6 mm needles, a dosing card, and a certificate of analysis (CoA) available on request [2][3].
The bundle is supplied for in-vitro laboratory research; the component evidence is documented per pen [1][4].
Key Takeaways
- The bundle groups three distinct research pens — MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg — which act through complementary metabolic mechanisms; each retains its own evidence base.
- Published literature addresses each component’s mechanism in its own body of work: the triple-agonist trial literature, the mitochondrial peptide research, and the NAD+ coenzyme literature.
- Confirm the bundle price at checkout; it is lower than the three pens bought separately.
- Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist; MOTS-C + SS-31 is a mitochondrial-focused peptide blend; NAD+ (nicotinamide adenine dinucleotide) is a metabolic coenzyme, all supplied for in-vitro research.
- Each pen ships with needles, a dosing card, and a CoA available on request.
Bundle Identity and Composition
This three-pen research stack comprises MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg, sold as a bundled purchase at a lower combined price than the three pens acquired separately, positioned by Veyvora as “the triple agonist, mitochondrial blend and NAD+, the deepest reset in the range” (Veyvora, 2026) [4].
Each pen retains its own product identity, quantity, and evidence base; the three are combined here because they address complementary points in metabolic research [4][5].
| Component | Total quantity | Format |
|---|---|---|
| MOTS-C + SS-31 | 40 mg | Multi-dose research pen |
| Retatrutide | 40 mg | Multi-dose research pen |
| NAD+ | 1000 mg | Multi-dose research pen |
Confirm the current bundle price at checkout before ordering [4], and stock availability on the live product page [5].
Included Components
The Advanced Metabolic Reset Research Bundle contains three separately identified research pens, each with its own quantity, per-click dose, and product page; the pens are supplied separately rather than as a combined formulation [4][5].
| Component | Total quantity | Per-click dose | Format | Accessories |
|---|---|---|---|---|
| MOTS-C + SS-31 | 40 mg | 133 µg | 3 mL, 300-click multi-dose research pen | 10 × 31G 6 mm needles, dosing card, CoA on request |
| Retatrutide | 40 mg | 133 µg | 3 mL, 300-click multi-dose research pen | 10 × 31G 6 mm needles, dosing card, CoA on request |
| NAD+ | 1000 mg | 3.33 mg | 3 mL, 300-click multi-dose research pen | 10 × 31G 6 mm needles, dosing card, CoA on request |
Sources: Veyvora product pages, 30 August 2026 [2][3][4].
Each pen is sealed at dispatch and supplied with needles and a dosing card [2][3]. Retatrutide is a triple GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptor agonist investigated in published clinical literature; MOTS-C + SS-31 is a mitochondrial-focused peptide blend; NAD+ (nicotinamide adenine dinucleotide) is a metabolic coenzyme. All three are supplied for in-vitro laboratory research [1][4].
Researchers comparing incretin receptor coverage across investigational compounds can consult the retatrutide versus tirzepatide comparison.
State of the Evidence
The published literature addresses each of the three components in its own body of work [1][4][5]. Retatrutide is studied as a triple GLP-1/GIP/glucagon receptor agonist in the incretin-class clinical literature; MOTS-C + SS-31 is studied as a mitochondrial-focused peptide blend, with MOTS-c and SS-31 each acting on mitochondrial function; and NAD+ is studied as a metabolic coenzyme central to cellular energy. Each addresses a complementary point in metabolic research, and the component-level framing on the live product pages follows the same map [1][4].
The mitochondrial research underpinning MOTS-c and SS-31 research and the coenzyme role documented in NAD+ research are separate bodies of work from the triple-agonist literature on Retatrutide [1][6], so each component is evaluated against its own evidence base, and the bundle brings the three threads together in one order.
Batch Documents and Handling
Each pen — MOTS-C + SS-31 40 mg, Retatrutide 40 mg, and NAD+ 1000 mg — ships with a CoA available on request that confirms batch identity and assay documentation at the component level [2][3][4]. Batch-specific sterility data, endotoxin values and cold-chain thresholds are reported per pen on its own documentation; request any handling requirement for the bundle as a grouped shipment from Veyvora before use [2][3][4].
Researchers can match a received pen to its published certificate using Veyvora’s verify your batch tool. For how the purity figure is measured and reported, consult what HPLC purity does and doesn’t prove: HPLC (high-performance liquid chromatography), mass spectrometry, and endotoxin assay each measure a distinct property of the material [4].
Shipping and Storage Conditions
Request the shipping temperature, cold-chain packaging specification and transit conditions for the bundle from Veyvora, or read them from the dispatch note or product page capture dated to the day of purchase [2][3][4]. For storage and handling instructions once the pens arrive, consult Veyvora’s storage guidance for research peptides before dispatch is arranged.
Commercial Terms
Veyvora lists the Advanced Metabolic Reset Research Bundle as a bundled research purchase at a lower combined price than buying the three pens separately, because the grouped format reduces per-unit cost relative to individual checkout [1]. GBP price, stock count and shipping service level are live values; confirm any specific figure directly from the live checkout flow before ordering [1]. Pricing and availability change, so the Veyvora product page on the date of purchase is the reference figure [1].
Research Use
Veyvora sells the Advanced Metabolic Reset Research Bundle for laboratory and in-vitro research, such as metabolic-signalling, mitochondrial-function and cellular-energy assays in cell culture, with each pen also usable as an analytical reference material [1][6]. Not for human or veterinary use. Retatrutide, the triple GLP-1/GIP/glucagon agonist in the stack, is an investigational compound in the current literature as of 30 August 2026 [1].
Sources
[1] Metabolic Research Pens | Veyvora, veyvora.com, https://veyvora.com/categories/metabolic [2] MOTS-C + SS-31 40 mg Pen | Veyvora, veyvora.com, https://veyvora.com/peptides/mots-c-ss31-40 [3] NAD+ 1000 mg Longevity Research Pen | Veyvora, veyvora.com, https://veyvora.com/peptides/nad-1000 [4] Veyvora, research peptides, measured to the microgram, veyvora.com, https://veyvora.com/ [5] Explore Research Peptides by Focus | Veyvora, veyvora.com, https://veyvora.com/categories [6] Longevity & Cellular Research Pens | Veyvora, veyvora.com, https://veyvora.com/categories/longevity
